Skip to main content
Log in

Growth hormone therapy in dilated cardiomyopathy monitored with MRI

  • Published:
Magnetic Resonance Materials in Physics, Biology and Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Dec GWFV. Idiopathic dilated cardiomyopathy. N Engl J Med 1994;331:1564–75.

    Article  Google Scholar 

  2. Fazio S, Sabatini D, Capaldo B, et al. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 1996;334:809–14.

    Article  PubMed  CAS  Google Scholar 

  3. Osterziel KJ, Strohm O, Schuler J, et al. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 1998;351:1233–7.

    Article  PubMed  CAS  Google Scholar 

  4. Mogelvang J, Lindvig K, Sondergaard L, Saunamaki K, Henriksen O. Reproducibility of cardiac volume measurements including left ventricular mass determined by MRI. Clin Physiol 1993;13:587–97.

    PubMed  CAS  Google Scholar 

  5. Germain P, Roul G, Kastler B, Mossard JM, Bareiss P, Sacrez A. Inter-study variability in left ventricular mass measurement. Comparison between M-mode echography and MRI. Eur Heart J 1992;13:1011–9.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Friedrich, M.G., Strohm, O., Osterziel, KJ. et al. Growth hormone therapy in dilated cardiomyopathy monitored with MRI. MAGMA 6, 152–154 (1998). https://doi.org/10.1007/BF02660943

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02660943

Keywords

Navigation